Liverpool Centre for Cardiovascular Science, Thoracic Aneurysm Service, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.
J Thorac Cardiovasc Surg. 2020 Apr;159(4):1189-1196.e1. doi: 10.1016/j.jtcvs.2019.03.097. Epub 2019 Apr 14.
We seek to assess the safety of total arch replacement with frozen elephant trunk for acute type A aortic dissection in respect to the risks of operative mortality, stroke, and paraplegia using an international multicenter registry (ARCH).
The ARCH Registry database from 37 participating centers was analyzed between 2000 and 2015. Patients who underwent emergency surgery for acute type A aortic dissection treated by total arch replacement with or without frozen elephant trunk were included. Operative mortality, permanent neurologic deficits, and spinal cord injury were primary end points. These end points were analyzed using univariate and hierarchical multivariate regression analyses, as well as conditional logistic regression analysis and post hoc propensity-score stratification.
A total of 11,928 patients were enrolled in the ARCH database, of which 6180 were managed with total arch replacement. A comprehensive analysis was performed for 978 patients who underwent total aortic arch replacement for acute type A aortic dissection with or without frozen elephant trunk placement. In propensity-score matching, there were no significant differences between total arch replacement and frozen elephant trunk in terms of permanent neurologic deficits (11.9% vs 10.1%, P = .59) and spinal cord injury (4.0% vs 6.3%, P = .52) For patients included in the post hoc propensity-score stratification, frozen elephant trunk was associated with a statistically significantly lower mortality risk (odds ratio, 0.47; P = .03).
The use of frozen elephant trunk for acute type A aortic dissection does not appear to increase the risk of paraplegia in appropriately selected patients at experienced centers. The exact risk factors for paraplegia remain to be determined.
我们旨在利用国际多中心注册研究(ARCH)评估在急性 A 型主动脉夹层中应用全主动脉弓置换联合冷冻象鼻技术的安全性,包括手术死亡率、卒中和截瘫的风险。
分析 2000 年至 2015 年期间来自 37 个参与中心的 ARCH 注册数据库,纳入接受急诊手术治疗的急性 A 型主动脉夹层患者,术式为全主动脉弓置换联合或不联合冷冻象鼻技术。手术死亡率、永久性神经功能障碍和脊髓损伤是主要终点。使用单变量和分层多变量回归分析、条件逻辑回归分析和事后倾向评分分层对这些终点进行分析。
ARCH 数据库共纳入 11928 例患者,其中 6180 例行全主动脉弓置换术。对 978 例行全主动脉弓置换术治疗急性 A 型主动脉夹层的患者进行了综合分析,其中包括联合或不联合冷冻象鼻技术。在倾向评分匹配后,全主动脉弓置换术和冷冻象鼻技术在永久性神经功能障碍(11.9%比 10.1%,P=.59)和脊髓损伤(4.0%比 6.3%,P=.52)方面无显著差异。对于事后倾向评分分层中纳入的患者,冷冻象鼻与死亡率显著降低相关(比值比,0.47;P=.03)。
在经验丰富的中心,对于合适选择的患者,应用冷冻象鼻技术治疗急性 A 型主动脉夹层似乎不会增加截瘫风险。截瘫的确切风险因素仍有待确定。